Home > Validation of two diagnostic assessments for opioid and stimulant use disorder for use by non‐clinicians.

Di Paola, Angela and Farabee, David and Springer, Sandra A (2023) Validation of two diagnostic assessments for opioid and stimulant use disorder for use by non‐clinicians. Psychiatric Research & Clinical Practice, 5, (3), pp. 78-83. https://doi.org/10.1176/appi.prcp.20230022.

External website: https://prcp.psychiatryonline.org/doi/10.1176/appi...


Highlights

  • The Rapid Opioid Dependence Screen has been updated to the Rapid Opioid Use Disorder Assessment (ROUDA) to identify those who meet DSM‐5 criteria for moderate to severe opioid use disorder.

  • The Rapid Stimulant Use Disorder Assessment (RSUDA) is a new valid tool that can be administered quickly and easily in a variety of settings to identify those with a moderate to severe stimulant use disorder per DSM‐5 criteria.

  • Both the ROUDA and RSUDA can be administered by clinical and non‐clinical personnel in a variety of settings, increasing the accessibility to opioid and/or stimulant use disorder diagnoses.

  • Identifying those with opioid and/or stimulant use disorder can provide a reachable moment for education, harm reduction, and linkage to treatment

Item Type
Article
Publication Type
International, Open Access, Article
Drug Type
Opioid
Intervention Type
Harm reduction
Date
2023
Identification #
https://doi.org/10.1176/appi.prcp.20230022
Page Range
pp. 78-83
Publisher
American Psychiatric Association
Volume
5
Number
3
EndNote

Repository Staff Only: item control page